Logo image of RGNX

REGENXBIO INC (RGNX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:RGNX - US75901B1070 - Common Stock

14.95 USD
-0.1 (-0.66%)
Last: 1/14/2026, 8:00:02 PM
14.869 USD
-0.08 (-0.54%)
After Hours: 1/14/2026, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RGNX revenue by date.RGNX revenue by date.
112.7M
-76.04%
90.242M
-19.93%
83.328M
-7.66%
193.99M
132.80%
281.91M
45.32%
371.39M
31.74%
498.98M
34.35%
683.93M
37.07%
885.41M
29.46%
1.129B
27.51%
1.201B
6.38%
1.232B
2.58%
EBITDA
YoY % growth
RGNX ebitda by date.RGNX ebitda by date.
-250M
-247.41%
-250.808M
-0.32%
-214.13M
14.62%
-109.554M
48.84%
-111.968M
-2.20%
-29.558M
73.60%
-30.486M
-3.14%
102.07M
434.81%
217.38M
112.97%
246.63M
13.46%
286.07M
15.99%
294.72M
3.02%
EBIT
YoY % growth
RGNX ebit by date.RGNX ebit by date.
-262.9M
-264.31%
-268.128M
-1.99%
-230.345M
14.09%
-133.657M
41.98%
-101.206M
24.28%
-82.084M
18.89%
-72.266M
11.96%
59.696M
182.61%
272.51M
356.50%
374M
37.24%
419.04M
12.04%
424.92M
1.40%
Operating Margin
RGNX operating margin by date.RGNX operating margin by date.
-233.27%-297.12%-276.43%-68.90%-35.90%-22.10%-14.48%8.73%30.78%33.13%34.89%34.49%
EPS
YoY % growth
RGNX eps by date.RGNX eps by date.
-6.50
-337.23%
-6.03
7.23%
-4.56
24.38%
-3.09
32.24%
-2.94
4.89%
-2.09
28.73%
-1.51
27.76%
0.66
143.82%
4.04
509.23%
8.55
111.74%
9.39
9.78%
9.20
-2.01%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.85
15.64%
-0.32
-368.60%
-0.89
35.70%
-0.94
21.80%
-0.16
81.80%
-1.01
-213.29%
-0.75
14.94%
-0.55
41.30%
-0.35
-123.68%
Revenue
Q2Q % growth
50.483M
137.97%
79.076M
-11.16%
53.29M
149.50%
47.397M
59.41%
91.18M
80.62%
31.396M
-60.30%
45.676M
-14.29%
59.956M
26.50%
81.967M
-10.10%
EBITDA
Q2Q % growth
-10.771M
69.36%
78.529M
388.30%
-40.026M
27.77%
-30.104M
25.97%
-57.12M
-430.33%
-48.042M
-161.18%
-35.18M
12.11%
-24.602M
18.27%
-13.984M
75.52%
EBIT
Q2Q % growth
-28.753M
44.03%
-508.47K
-104.19%
-36.648M
42.08%
-56.363M
-7.54%
-4.607M
83.98%
-52.081M
-10,142.73%
-39.168M
-6.88%
-28.57M
49.31%
-18.095M
-292.77%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-1.20
-2.56%
-1.330.139.88%
Q2 2025
Q2Q % growth
-1.38
-31.43%
-1.12-0.26-22.99%
Q1 2025
Q2Q % growth
0.12
109.02%
0.49-0.37-75.63%
Q4 2024
Q2Q % growth
-1.01
29.37%
-1.170.1613.65%
Q3 2024
Q2Q % growth
-1.17
17.02%
-1.14-0.03-2.21%
Q2 2024
Q2Q % growth
-1.05
36.75%
-1.320.2720.28%
Q1 2024
Q2Q % growth
-1.33
13.07%
-1.28-0.05-3.57%
Q4 2023
Q2Q % growth
-1.43
-3.62%
-1.30-0.13-10.34%
Q3 2023
Q2Q % growth
-1.41
19.43%
-1.550.148.92%
Q2 2023
Q2Q % growth
-1.66
-5.06%
-1.41-0.25-17.51%
Q1 2023
Q2Q % growth
-1.53
14.53%
-1.570.042.39%
Q4 2022
Q2Q % growth
-1.38
-120.69%
-1.26-0.12-9.61%
Q3 2022
Q2Q % growth
-1.75
-27.74%
-1.49-0.26-17.40%
Q2 2022
Q2Q % growth
-1.58
-16.18%
-1.56-0.02-1.43%
Q1 2022
Q2Q % growth
-1.79
-49.17%
-1.34-0.45-33.35%
Q4 2021
Q2Q % growth
6.67
637.90%
4.811.8638.79%
Q3 2021
Q2Q % growth
-1.37
-418.60%
-1.10-0.27-24.56%
Q2 2021
Q2Q % growth
-1.36
-49.45%
-1.14-0.22-19.51%
Q1 2021
Q2Q % growth
-1.20
-11.11%
-1.310.118.29%
Q4 2020
Q2Q % growth
-1.24 -0.44-0.80-179.92%
Q3 2020
Q2Q % growth
0.43 -1.031.46141.67%
Q2 2020
Q2Q % growth
-0.91 -0.90-0.01-0.69%
Q1 2020
Q2Q % growth
-1.08 -0.89-0.19-21.70%
RGNX Yearly EPS VS EstimatesRGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 -5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
29.733M
22.88%
24.608M5.125M20.83%
Q2 2025
Q2Q % growth
21.359M
-4.20%
28.675M-7.316M-25.51%
Q1 2025
Q2Q % growth
89.012M
469.79%
104.01M-14.998M-14.42%
Q4 2024
Q2Q % growth
21.214M
-4.50%
24.229M-3.015M-12.44%
Q3 2024
Q2Q % growth
24.197M
-16.31%
24.06M137K0.57%
Q2 2024
Q2Q % growth
22.295M
11.60%
23.432M-1.137M-4.85%
Q1 2024
Q2Q % growth
15.622M
-18.37%
23.995M-8.373M-34.89%
Q4 2023
Q2Q % growth
22.213M
-29.03%
34.679M-12.466M-35.95%
Q3 2023
Q2Q % growth
28.914M
9.11%
26.687M2.227M8.34%
Q2 2023
Q2Q % growth
19.977M
-38.72%
35.195M-15.218M-43.24%
Q1 2023
Q2Q % growth
19.138M
-13.79%
31.208M-12.07M-38.68%
Q4 2022
Q2Q % growth
31.3M
-92.15%
38.2M-6.9M-18.06%
Q3 2022
Q2Q % growth
26.5M
-13.96%
31.428M-4.928M-15.68%
Q2 2022
Q2Q % growth
32.6M
48.18%
27.322M5.278M19.32%
Q1 2022
Q2Q % growth
22.2M
17.46%
29.792M-7.592M-25.48%
Q4 2021
Q2Q % growth
398.7M
1,763.08%
277.17M121.53M43.85%
Q3 2021
Q2Q % growth
30.8M
-68.86%
42.294M-11.494M-27.18%
Q2 2021
Q2Q % growth
22M
32.53%
29.603M-7.603M-25.68%
Q1 2021
Q2Q % growth
18.9M
7.39%
23.697M-4.797M-20.24%
Q4 2020
Q2Q % growth
21.4M 62.733M-41.333M-65.89%
Q3 2020
Q2Q % growth
98.9M 21.793M77.107M353.82%
Q2 2020
Q2Q % growth
16.6M 22.511M-5.911M-26.26%
Q1 2020
Q2Q % growth
17.6M 18.819M-1.219M-6.48%
RGNX Yearly Revenue VS EstimatesRGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.12% -878.83% 0% -25.14%
Revenue0% -44.38% 0% -23.37%